According to the Zhitong Finance App, Tailin Biotech (300813.SZ) released its report for the third quarter of 2026. In the first three quarters, the company achieved revenue of 255 million yuan, an increase of 19.58% over the previous year. Net profit attributable to shareholders of listed companies was RMB 28.773 million, a year-on-year increase of 90.70%. Net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was RMB 21.32,500, an increase of 63.41% over the previous year.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.